RECRUITING

Physical Activity to Mitigate PreEclampsia Risk

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to compare the effects of aerobic (AE), resistance (RE), and combination (AERE) exercise throughout pregnancy on selected maternal and fetal/neonatal physiological variables in women at-risk for preeclampsia. The central hypothesis of this project is that exercise will decrease severity and occurrence of preeclampsia symptoms, thus improving maternal, pregnancy, and birth outcomes. Aim 1. Determine the influence of different exercise modes during pregnancy at risk of preeclampsia on maternal cardiometabolic health. Aim 2. Determine the most effective exercise mode in pregnancy at risk of preeclampsia on improving birth and infant health outcomes.

Official Title

Physical Activity to Mitigate PreEclampsia Risk (PAMPER)

Quick Facts

Study Start:2024-06-24
Study Completion:2026-10-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06319014

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 40 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * healthy women, age 18-40 years, \<16 weeks' gestation, with singleton pregnancy; women (BMI:18.5-45.0), sedentary, cleared by their obstetric provider.
  1. * pre-existing chronic conditions such as HIV, lupus, etc.; taking medicines that affect fetal development; and/or lack of telephone or email contact information).

Contacts and Locations

Study Contact

Linda E May, MS, PhD
CONTACT
2527377072
mayl@ecu.edu
James DeVente, MD
CONTACT
deventeja@ecu.edu

Principal Investigator

Linda E May, MS, PhD
PRINCIPAL_INVESTIGATOR
East Carolina University

Study Locations (Sites)

East Carolina University
Greenville, North Carolina, 27834
United States

Collaborators and Investigators

Sponsor: East Carolina University

  • Linda E May, MS, PhD, PRINCIPAL_INVESTIGATOR, East Carolina University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-24
Study Completion Date2026-10-01

Study Record Updates

Study Start Date2024-06-24
Study Completion Date2026-10-01

Terms related to this study

Additional Relevant MeSH Terms

  • Pre-Eclampsia